Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty

Am J Cardiol. 1995 Dec 1;76(16):1185-8. doi: 10.1016/s0002-9149(99)80334-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Angioplasty, Balloon, Coronary*
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Anticholesteremic Agents / administration & dosage*
  • Colchicine / administration & dosage*
  • Combined Modality Therapy
  • Coronary Angiography
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / therapy*
  • Drug Therapy, Combination
  • Enalapril / administration & dosage*
  • Female
  • Humans
  • Lovastatin / administration & dosage*
  • Male
  • Middle Aged
  • Pilot Projects
  • Recurrence

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Anticholesteremic Agents
  • Enalapril
  • Lovastatin
  • Colchicine